Zhou Jian, Wang Zheng, Qiu Shuang-Jian, Huang Xiao-Wu, Sun Jian, Gu Wen, Fan Jia
Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
J Cancer Res Clin Oncol. 2010 Sep;136(9):1453-60. doi: 10.1007/s00432-010-0802-2. Epub 2010 Feb 11.
The optimum strategy, hepatic resection (HR) or liver transplantation (LT), for treatment of early hepatocellular carcinoma (HCC) associated with liver diseases of Child-Pugh A is far from established. The aim of this study was to compare and determine which strategy is optimal for HCC fulfilling the Milan criteria.
Consecutive data were collected in 1,018 HCC patients treated with HR and 89 HCC patients listed for LT (1 drop out for HCC progression) between January of 2003 and December of 2007.
The independent prognostic factors identified by multivariate analysis were tumor size-plus-number, microscopic venous invasion, and operation type (LT or HR). When tumor size-plus-number was < or =4 or microscopic venous invasion was absent, there was no significant difference in overall survival (OS) between the LT and HR group. When tumor size-plus-number was >4 or microscopic venous invasion was present, OS was higher in the LT group.
Since the pathological microscopic venous invasion was not easily available before operation which is limitation for widespread clinical use, thus in practice, we concluded that, for early HCC associated with Child-Pugh A cirrhosis, when tumor size-plus-number is >4, LT provides the best cure; when it is < or =4, HR remains the initial treatment of choice.
治疗与Child-Pugh A级肝病相关的早期肝细胞癌(HCC)的最佳策略,即肝切除术(HR)还是肝移植术(LT),尚未完全确立。本研究的目的是比较并确定哪种策略对符合米兰标准的HCC最为合适。
收集了2003年1月至2007年12月期间接受HR治疗的1018例HCC患者以及列入LT名单的89例HCC患者(1例因HCC进展退出)的连续数据。
多变量分析确定的独立预后因素为肿瘤大小加数量、显微镜下静脉侵犯和手术类型(LT或HR)。当肿瘤大小加数量≤4或无显微镜下静脉侵犯时,LT组和HR组的总生存期(OS)无显著差异。当肿瘤大小加数量>4或存在显微镜下静脉侵犯时,LT组的OS更高。
由于术前难以获得病理显微镜下静脉侵犯情况,这限制了其在临床上的广泛应用,因此在实践中,我们得出结论,对于与Child-Pugh A级肝硬化相关的早期HCC,当肿瘤大小加数量>4时,LT提供最佳治愈效果;当≤4时,HR仍是首选的初始治疗方法。